Obalon Announces Upcoming Conference Presentations
06 nov. 2018 09h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2018 Financial Results
02 nov. 2018 08h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time
23 oct. 2018 09h04 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
26 sept. 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018
29 août 2018 09h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics Announces Closing of $10 Million Private Placement
27 août 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
07 août 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Promotes Kelly Huang, Ph.D. to President
02 août 2018 07h55 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the promotion of Kelly Huang to the position of President, effective August 2, 2018. “Kelly...
Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time
24 juil. 2018 10h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 24, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
06 juin 2018 09h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only...